4528 JPX Week ended 07 Aug 2026

Weekly Investor Report

Ono Pharmaceutical Co., Ltd. · Healthcare · Drug Manufacturers - General

Open interactive chart View report data
Latest close 2,380 JPY
-0.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -0.9% below the Trend Line and sits at 77.0% of its 52-week range. The latest completed week returned -0.1%, after a -2.0% four-week move. The latest news-sentiment score is 54/100.

Setup score 49 out of 100
Latest Close 2,380 JPY 7 Aug 2026
1W Return -0.1% latest completed week
4W Return -2.0% short-term follow-through
12W Return -6.0% quarterly tape
Trend Breadth 82.7% 43 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.1% Latest completed week; four-week move -2.0%. Indicator stack 45/52 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 54/100 15 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -0.9% below the Trend Line and sits at 77.0% of its 52-week range. The latest completed week returned -0.1%, after a -2.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6212-week average 0.66

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.62Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.0% over four weeks, -6.0% over 12 weeks, and 45.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-0.1%
4W-2.0%
12W-6.0%
26W-2.7%
52W45.0%
Active trend streak0 weeks
Active weeks in one year43
Trend breadth82.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.24Latest activity-pressure read.
Pressure change78.9%Four-week change in activity pressure.
Leadership-8.55Latest relative-leadership reading.
RS change22.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 15 relevant articles.

4 positive · 11 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.6%Distance below the 52-week high.
13-week volatility3.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+8.5%Week of 27 Mar.
Worst week-7.0%Week of 5 Jun.
Latest week-0.1%Week of 7 Aug.

Shape of recent returns

Strong gains3
Modest gains9
Flat weeks0
Modest losses10
Sharp losses4
Recent vol3.0%13-week weekly-return volatility.
Base vol3.4%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew2.9% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape50/100

Trend, activity pressure, participation, and risk combine to a 50/100 tape read.

 Indicator analysis22/100

Latest 12-week confirmation: trend 3/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.62; 2 reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 15 relevant articles.

Ono Pharmaceutical Co., Ltd. 2027 Q1 - Results - Earnings Call Presentation (OTCMKTS:OPHLY) 2026-08-04 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20262,380 JPY-0.1%2,402 JPY2,024 JPY-0.24-8.558.3MOff
31 Jul 20262,384 JPY-2.1%2,397 JPY2,025 JPY-0.37-6.7810.5MOff
24 Jul 20262,435 JPY0.4%2,389 JPY2,025 JPY-0.64-5.235.3MOff
17 Jul 20262,426 JPY-0.1%2,380 JPY2,024 JPY-0.82-4.917.6MOff
10 Jul 20262,428 JPY0.4%2,370 JPY2,024 JPY-1.13-10.986.5MOff
3 Jul 20262,419 JPY1.7%2,361 JPY2,023 JPY-1.42-12.981.1MOff
26 Jun 20262,378 JPY5.7%2,349 JPY2,021 JPY-1.56-14.151.4MOff
19 Jun 20262,249 JPY1.6%2,342 JPY2,021 JPY-1.58-21.042.2MOff
12 Jun 20262,212 JPY-0.6%2,335 JPY2,022 JPY-1.35-16.471.9MOff
5 Jun 20262,225 JPY-7.0%2,328 JPY2,024 JPY-1.05-16.961.6MOn
29 May 20262,392 JPY-3.6%2,318 JPY2,025 JPY-0.82-10.568.6MOn
22 May 20262,482 JPY-2.0%2,299 JPY2,025 JPY-0.88-2.989.6MOn
15 May 20262,534 JPY2.1%2,277 JPY2,024 JPY-0.982.089.7MOn
8 May 20262,480 JPY7.1%2,252 JPY2,022 JPY-1.07-2.017.9MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.